S14 Ep36: Evolving Research Paradigms, Real-World Data, and Multidisciplinary Collaboration Enhance Bladder Cancer Management: With Amit Mehta, MD
OncLive® On Air
00:00
Impact of Enfortumab Vedotin plus Pembrolizumab Approval
Amit Mehta explains how the FDA approval and phase III publication changed first-line metastatic urothelial carcinoma practice.
Play episode from 00:46
Transcript
